OmegaGenics EPA 500 Concentrate
Natural health product licensed in Canada
- Other names
- Concentrated EPA, OmegaGenics EPA 500 EC
- Licence holder
- Metagenics Inc.
- NPN or DIN-HM
- 80048287
- Status
- Inactive licence
- Licence date
- 11 February 2014
- Revision date
- 21 December 2015
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Engraulidae - en entier Potency : 500 mg Eicosapentaenoic acid | 1,175 g | Not calculated |
| Huile de poisson Source : Engraulidae - en entier Potency : 80 mg Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 500 mg Eicosapentaenoic acid | 1,175 g | Not calculated |
| Huile de poisson Source : Scombridae - en entier Potency : 80 mg Docosahexaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 500 mg Eicosapentaenoic acid | 1,175 g | Not calculated |
| Huile de poisson Source : Clupeidae - en entier Potency : 80 mg Docosahexaenoic acid | Not specified | Not calculated |
Non-medicinal ingredients
Extrait de romarin, Vanillin, Triacétine, Gélatine, Tocophérols, Saveur, Monostéarate de glycéryle, Palmitate d'ascorbyle, (p)-hydroxybenzoate de propyle, propylèneglycol, Glycérine, Eau, (p)-hydroxybenzoate de méthyle, Copolymère d'acide méthacrylique, Citrate de triéthyle, Poly(sorbate) 80
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 9 years ; maximum: 13 years | 1 Capsule | 2 Tous les jours |
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 4 Capsule | 1 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 8 years | 1 Capsule | 2 Tous les jours |
| Adolescentes | minimum: 14 years ; maximum: 18 years | minimum: 2 Capsule ; maximum: 4 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps support cognitive health and/or brain function. Source of omega-3 fatty acids for the maintenance of good health. Helps support the development of the brain, eyes and nerves in children up to 12 years of age.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80048287
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2015. Photograph the packaging to check whether it has changed. Photograph the packaging